Exosomes Transfer ST6GAL1-mediated Therapeutic Resistance in Rectal Cancer Cells.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Locally advanced rectal cancer (RC) often exhibits resistance to neoadjuvant chemoradiation.
• ST6GAL1 has been identified as a key factor contributing to this chemoradiation resistance in RC.
• Exosomes, as intercellular communicators, are investigated for their role in mediating treatment resistance.

Purpose of the Study:

• To investigate the hypothesis that exosomes transfer ST6GAL1 between rectal cancer cells, thereby spreading chemoradiation resistance.
• To elucidate the mechanism by which ST6GAL1 is transferred and its functional impact on cancer cells.

Main Methods:

• Characterization of exosomes isolated from ST6GAL1-expressing colorectal cancer (CRC) cell lines.
• Assessment of treatment response in ST6GAL1-knockdown (KD) CRC cells upon exosome treatment.
• Single cell RNA sequencing (scRNA-seq) and flow cytometry on CRC organoids to analyze ST6GAL1 RNA and protein activity.

Main Results:

• Exosomes from CRC cells were confirmed to contain ST6GAL1 protein.
• ST6GAL1 protein transfer to KD cells was observed, increasing protein levels without altering mRNA, and localizing to the Golgi complex.
• Treated cells exhibited significantly increased resistance to chemoradiation-induced apoptosis and enhanced colony formation.
• scRNA-seq revealed widespread ST6GAL1 protein activity (86%) despite limited mRNA expression (16%).

Conclusions:

• ST6GAL1-containing exosomes effectively transfer ST6GAL1 between rectal cancer cells.
• This exosomal transfer of ST6GAL1 is a mechanism that confers and spreads chemoradiation resistance in rectal cancer.